As shown in Supplementary Figure S3, CD41a.CD61 was most frequently expressed in AMKL patients (59/65; 91%), followed by CD42b (52/65; 80%) and CD41 46/65 (71%). This evidence concerns the gene GP1BA and acute megakaryoblastic leukemia.